Edit |   |
---|---|
Antigenic Specificity | CD40LG (Ruplizumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Ruplizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD40LG, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ruplizumab is a humanized monoclonal antibody that has been used as an immunosuppressant and is a component of Antova. Ruplizumab is an anti-CD40L monoclonal antibody. The binding of CD40 to its ligand, CD40L is a critical element in T cell activation. In systemic lupus erythematosus, CD40L is over-expressed on T cells, B cells and monocytes. |
Immunogen | n/a |
Other Names | Ruplizumab, CD40LG, 220651-94-5 |
Gene, Accession # | CAS: 220651-94-5 |
Catalog # | abx831002 |
Price | please inquire |
Order / More Info | CD40LG (Ruplizumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950